Free Trial

HTG Molecular Diagnostics (HTGMQ) Competitors

$0.0025
0.00 (0.00%)
(As of 05/31/2024 ET)

HTGMQ vs. NSTG, IDXG, PRPO, CHEK, PMD, A, MTD, WAT, ILMN, and AVTR

Should you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include NanoString Technologies (NSTG), Interpace Biosciences (IDXG), Precipio (PRPO), Check-Cap (CHEK), Psychemedics (PMD), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), and Avantor (AVTR).

HTG Molecular Diagnostics vs.

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and NanoString Technologies (NASDAQ:NSTG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings.

HTG Molecular Diagnostics has higher earnings, but lower revenue than NanoString Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A
NanoString Technologies$127.26M0.00-$159.54M-$3.53N/A

HTG Molecular Diagnostics has a beta of 2.73, meaning that its share price is 173% more volatile than the S&P 500. Comparatively, NanoString Technologies has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500.

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled NanoString Technologies'average media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
NanoString Technologies Neutral

NanoString Technologies has a consensus target price of $7.63, indicating a potential upside of ∞. Given NanoString Technologies' higher possible upside, analysts clearly believe NanoString Technologies is more favorable than HTG Molecular Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HTG Molecular Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
NanoString Technologies
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

HTG Molecular Diagnostics has a net margin of 0.00% compared to NanoString Technologies' net margin of -102.44%. HTG Molecular Diagnostics' return on equity of 0.00% beat NanoString Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
NanoString Technologies -102.44%-548.25%-53.79%

NanoString Technologies received 504 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.

CompanyUnderperformOutperform
HTG Molecular DiagnosticsN/AN/A
NanoString TechnologiesOutperform Votes
504
63.16%
Underperform Votes
294
36.84%

Summary

HTG Molecular Diagnostics beats NanoString Technologies on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

MetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$6,000.00$4.94B$5.07B$7.96B
Dividend YieldN/A0.39%2.75%4.02%
P/E RatioN/A30.71172.7318.29
Price / Sales0.006.222,378.2782.56
Price / Cash0.0136.8334.3930.90
Price / Book0.002.305.504.59
Net Income-$21.59M-$10.98M$105.62M$213.79M
7 Day PerformanceN/A-1.87%1.10%0.65%
1 Month PerformanceN/A-4.17%3.25%3.48%
1 Year PerformanceN/A-27.22%4.96%8.81%

HTG Molecular Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NSTG
NanoString Technologies
1.4453 of 5 stars
N/A$7.63
+∞
N/A$5.07M$127.26M-0.03550Gap Down
IDXG
Interpace Biosciences
0 of 5 stars
$1.48
+7.2%
N/A-44.3%$6.47M$40.21M0.00152
PRPO
Precipio
1.4872 of 5 stars
$5.87
-3.3%
$40.00
+581.4%
-50.3%$8.63M$15.20M-1.7251Short Interest ↓
Positive News
Gap Down
CHEK
Check-Cap
0 of 5 stars
$2.27
flat
N/A+53.0%$13.28MN/A-0.7685Upcoming Earnings
News Coverage
PMD
Psychemedics
0 of 5 stars
$2.57
-4.5%
N/A-49.4%$14.92M$22.10M-3.34116Short Interest ↓
Positive News
Gap Down
A
Agilent Technologies
4.3582 of 5 stars
$150.66
+0.1%
$141.06
-6.4%
+12.7%$44.15B$6.83B35.8718,100Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
MTD
Mettler-Toledo International
3.5232 of 5 stars
$1,479.53
+0.0%
$1,257.14
-15.0%
+6.2%$31.60B$3.79B41.4917,300Positive News
WAT
Waters
3.8246 of 5 stars
$336.46
-0.1%
$305.78
-9.1%
+23.0%$19.96B$2.96B33.027,900Insider Buying
Analyst Revision
ILMN
Illumina
4.6861 of 5 stars
$106.48
+0.6%
$164.65
+54.6%
-47.0%$16.96B$4.50B-13.079,300Short Interest ↑
AVTR
Avantor
4.3884 of 5 stars
$24.14
-0.2%
$26.71
+10.7%
+20.8%$16.40B$6.97B61.9014,500Short Interest ↓
Positive News

Related Companies and Tools

This page (NASDAQ:HTGMQ) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners